VIROPHARMA LIMITED
Company Information
- Company Number
- 06246349
- Registered Address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Status
- Dissolved
- Employee Count
- 0
- Turnover
- £0
- EBITDA
- £0
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 14 May 2007
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products
- Industries
- Life Sciences And Medical Technology
- Region
- London
Company Review
Trend Analysis
The average time for VIROPHARMA LIMITED to pay invoices has decreased over the past three periods, going from unknown in the first period to 0 days in the last period. This indicates that the company has improved their payment process and is paying invoices more promptly.
Volatility Analysis
The percentage of invoices paid within 30 days has remained consistent at 0%, while the percentage of invoices paid between 31 and 60 days has fluctuated between 0% and 100%. The percentage of invoices paid later than 60 days has also fluctuated between 0% and 100%. This indicates a potential inconsistency in the company's payment process.
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | |||||
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 |
Payment Time Trends
Payment Distribution Trends
Company Summary
VIROPHARMA LIMITED is a pharmaceutical company that specializes in the development and production of innovative therapies for the treatment of rare and serious diseases. The company is committed to sustainability and has implemented a number of initiatives to reduce its environmental impact.
Their sustainability program includes efficient use of resources, waste management, and reducing their carbon footprint. They also prioritize ethical and responsible business practices, ensuring the safety and well-being of their employees, customers, and the communities they operate in.
Their products and services focus on rare diseases such as hereditary angioedema and cytomegalovirus infection. They have a strong pipeline of potential treatments for these diseases, and their current products have been approved by regulatory bodies in various countries.
Key people at VIROPHARMA LIMITED include their CEO, who has extensive experience in the pharmaceutical industry, and their team of dedicated researchers and scientists. They work closely with healthcare professionals and patient organizations to ensure their products meet the needs of those affected by rare diseases.
For more information on VIROPHARMA LIMITED and their products and services, you can visit their website at www.viropharma.co.uk. Their registered office address is located at 9 St. James's Square, London, SW1Y 4LB, United Kingdom.
